Vespula pensylvanica isolate Volc-1 chromosome 22, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025357.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
etoposide-induced protein 2.4 homolog, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
etoposide-induced protein 2.4 homolog, transcript variant X1
etoposide-induced protein 2.4 homolog, transcript variant X3
etoposide-induced protein 2.4 homolog isoform X1
etoposide-induced protein 2.4 homolog isoform X2
transforming growth factor beta regulator 1, transcript variant X2
transforming growth factor beta regulator 1, transcript variant X1
transforming growth factor beta regulator 1 isoform X2
transforming growth factor beta regulator 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CUGBP Elav-like family member 1, transcript variant X18
CUGBP Elav-like family member 1, transcript variant X20
CUGBP Elav-like family member 1, transcript variant X17
CUGBP Elav-like family member 1, transcript variant X19
CUGBP Elav-like family member 1, transcript variant X13
CUGBP Elav-like family member 1, transcript variant X10
CUGBP Elav-like family member 1, transcript variant X15
CUGBP Elav-like family member 1, transcript variant X14
CUGBP Elav-like family member 1, transcript variant X8
CUGBP Elav-like family member 1, transcript variant X5
CUGBP Elav-like family member 1, transcript variant X9
CUGBP Elav-like family member 1, transcript variant X2
CUGBP Elav-like family member 1, transcript variant X12
CUGBP Elav-like family member 1, transcript variant X11
CUGBP Elav-like family member 1, transcript variant X3
CUGBP Elav-like family member 1, transcript variant X4
CUGBP Elav-like family member 1, transcript variant X6
CUGBP Elav-like family member 1, transcript variant X7
CUGBP Elav-like family member 1, transcript variant X1
CUGBP Elav-like family member 1, transcript variant X26
CUGBP Elav-like family member 1, transcript variant X29
CUGBP Elav-like family member 1, transcript variant X25
CUGBP Elav-like family member 1, transcript variant X23
CUGBP Elav-like family member 1, transcript variant X22
CUGBP Elav-like family member 1, transcript variant X16
CUGBP Elav-like family member 1, transcript variant X30
CUGBP Elav-like family member 1, transcript variant X32
CUGBP Elav-like family member 1, transcript variant X33
CUGBP Elav-like family member 1, transcript variant X21
CUGBP Elav-like family member 1, transcript variant X34
CUGBP Elav-like family member 1, transcript variant X31
CUGBP Elav-like family member 1, transcript variant X24
CUGBP Elav-like family member 1, transcript variant X27
CUGBP Elav-like family member 1, transcript variant X28
CUGBP Elav-like family member 1, transcript variant X37
CUGBP Elav-like family member 1, transcript variant X36
CUGBP Elav-like family member 1, transcript variant X35
CUGBP Elav-like family member 2 isoform X12
CUGBP Elav-like family member 2 isoform X8
CUGBP Elav-like family member 2 isoform X4
CUGBP Elav-like family member 2 isoform X2
CUGBP Elav-like family member 1 isoform X14
CUGBP Elav-like family member 1 isoform X10
CUGBP Elav-like family member 1 isoform X13
CUGBP Elav-like family member 1 isoform X6
CUGBP Elav-like family member 1 isoform X3
CUGBP Elav-like family member 1 isoform X11
CUGBP Elav-like family member 1 isoform X5
CUGBP Elav-like family member 1 isoform X7
CUGBP Elav-like family member 2 isoform X1
CUGBP Elav-like family member 2 isoform X9
CUGBP Elav-like family member 2 isoform X16
CUGBP Elav-like family member 2 isoform X15
CUGBP Elav-like family member 2 isoform X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
cytoplasmic dynein 2 light intermediate chain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cytoplasmic dynein 2 light intermediate chain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytoplasmic dynein 2 light intermediate chain 1
uncharacterized LOC122636594, transcript variant X2
uncharacterized LOC122636594, transcript variant X1
uncharacterized LOC122636594, transcript variant X3
vacuolar protein sorting-associated protein 54, transcript variant X1
vacuolar protein sorting-associated protein 54, transcript variant X3
vacuolar protein sorting-associated protein 54, transcript variant X2
vacuolar protein sorting-associated protein 54 isoform X2
vacuolar protein sorting-associated protein 54 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122636460, transcript variant X3
uncharacterized LOC122636460, transcript variant X2
uncharacterized LOC122636460, transcript variant X1
uncharacterized protein LOC122636460 isoform X2
uncharacterized protein LOC122636460 isoform X1
uncharacterized protein LOC122636460 isoform X3
uncharacterized LOC122636459, transcript variant X2
uncharacterized LOC122636459, transcript variant X3
uncharacterized LOC122636459, transcript variant X1
radial spoke head 1 homolog, transcript variant X2
radial spoke head 1 homolog, transcript variant X1
radial spoke head 1 homolog, transcript variant X3
RNA-binding protein 42, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
RNA-binding protein 42, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ER membrane protein complex subunit 7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
DNA-binding protein D-ETS-6-like, transcript variant X2
DNA-binding protein D-ETS-6-like, transcript variant X1
40S ribosomal protein S12, transcript variant X1
40S ribosomal protein S12, transcript variant X2
zinc finger MYND domain-containing protein 10
serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 3-like
furin-like protease 2, transcript variant X1
furin-like protease 2, transcript variant X2
SET and MYND domain-containing protein 4-like, transcript variant X3
SET and MYND domain-containing protein 4-like, transcript variant X2
SET and MYND domain-containing protein 4-like, transcript variant X1
SET and MYND domain-containing protein 4-like
guanine nucleotide-binding protein-like 1, transcript variant X2
guanine nucleotide-binding protein-like 1, transcript variant X1
guanine nucleotide-binding protein-like 1 isoform X1
guanine nucleotide-binding protein-like 1 isoform X2
putative fatty acyl-CoA reductase CG5065, transcript variant X3
putative fatty acyl-CoA reductase CG5065, transcript variant X1
putative fatty acyl-CoA reductase CG5065, transcript variant X2
putative fatty acyl-CoA reductase CG5065
biogenesis of lysosome-related organelles complex 1 subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transcription initiation factor TFIID subunit 11
frataxin homolog, mitochondrial, transcript variant X1
frataxin homolog, mitochondrial, transcript variant X2
frataxin homolog, mitochondrial isoform X1
frataxin homolog, mitochondrial isoform X2
uncharacterized LOC122636472, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122636472, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122636472, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC122636472 isoform X1
uncharacterized protein LOC122636472 isoform X4
uncharacterized protein LOC122636472 isoform X3
uncharacterized LOC122636472, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC122636472 isoform X2
pyruvate kinase-like, transcript variant X2
pyruvate kinase-like, transcript variant X1
pyruvate kinase-like, transcript variant X3
protein kinase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protein kinase 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
protein kinase 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
adrenodoxin-like protein 2, mitochondrial
kinesin-like protein KIF13B, transcript variant X1
kinesin-like protein KIF13B, transcript variant X3
kinesin-like protein KIF13B, transcript variant X2
kinesin-like protein KIF13B, transcript variant X5
kinesin-like protein KIF13B, transcript variant X6
kinesin-like protein KIF13B, transcript variant X4
kinesin-like protein KIF13B, transcript variant X7
matrix metalloproteinase-14, transcript variant X1
matrix metalloproteinase-14, transcript variant X3
matrix metalloproteinase-14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
matrix metalloproteinase-14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
E3 ubiquitin-protein ligase MSL2, transcript variant X2
E3 ubiquitin-protein ligase MSL2, transcript variant X1
E3 ubiquitin-protein ligase MSL2 isoform X2
E3 ubiquitin-protein ligase MSL2 isoform X1
E3 ubiquitin-protein ligase MSL2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
E3 ubiquitin-protein ligase MSL2 isoform X3
U2 snRNP-associated SURP motif-containing protein, transcript variant X2
U2 snRNP-associated SURP motif-containing protein, transcript variant X1
U2 snRNP-associated SURP motif-containing protein isoform X1
U2 snRNP-associated SURP motif-containing protein isoform X2
helicase SWR1-like, transcript variant X1
helicase SWR1-like, transcript variant X2
ras GTPase-activating protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ras GTPase-activating protein 3 isoform X6
ras GTPase-activating protein 3, transcript variant X3
ras GTPase-activating protein 3, transcript variant X1
ras GTPase-activating protein 3, transcript variant X2
ras GTPase-activating protein 3, transcript variant X4
ras GTPase-activating protein 3, transcript variant X8
ras GTPase-activating protein 3, transcript variant X7
ras GTPase-activating protein 3, transcript variant X5
ras GTPase-activating protein 3, transcript variant X10
ras GTPase-activating protein 3, transcript variant X9
ras GTPase-activating protein 3 isoform X2
ras GTPase-activating protein 3 isoform X3
ras GTPase-activating protein 3 isoform X1
ras GTPase-activating protein 3 isoform X4
ras GTPase-activating protein 3 isoform X8
ras GTPase-activating protein 3 isoform X5
uncharacterized LOC122636583, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122636583, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122636587, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122636587, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
A-kinase anchor protein 10, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
A-kinase anchor protein 10, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
A-kinase anchor protein 10, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
A-kinase anchor protein 10, mitochondrial isoform X1
A-kinase anchor protein 10, mitochondrial isoform X2
A-kinase anchor protein 10, mitochondrial isoform X3
uncharacterized LOC122636579, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC122636579, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC122636579 isoform X1
uncharacterized protein LOC122636579 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122636552, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC122636552, transcript variant X1
uncharacterized LOC122636552, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC122636552, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein LOC122636552 isoform X1
uncharacterized protein LOC122636552 isoform X3
uncharacterized protein LOC122636552 isoform X2
FGGY carbohydrate kinase domain-containing protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein isoform X1
FGGY carbohydrate kinase domain-containing protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein isoform X2
FGGY carbohydrate kinase domain-containing protein isoform X3
uncharacterized LOC122636569, transcript variant X2
uncharacterized LOC122636569, transcript variant X1
uncharacterized protein LOC122636569 isoform X2
uncharacterized protein LOC122636569 isoform X1
protein yippee-like 1, transcript variant X2
protein yippee-like 1, transcript variant X1
uncharacterized LOC122636570, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC122636570, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122636570, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC122636578, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122636578, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122636578, transcript variant X3
uncharacterized LOC122636578, transcript variant X1
uncharacterized LOC122636578, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC122636578 isoform X2
uncharacterized protein LOC122636578 isoform X1
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X2
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X4
insulin-like growth factor 2 mRNA-binding protein 1 isoform X2
insulin-like growth factor 2 mRNA-binding protein 1 isoform X4
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X5
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X6
insulin-like growth factor 2 mRNA-binding protein 1 isoform X5
insulin-like growth factor 2 mRNA-binding protein 1 isoform X6
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X1
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X3
insulin-like growth factor 2 mRNA-binding protein 1 isoform X1
insulin-like growth factor 2 mRNA-binding protein 1 isoform X3
insulin-like growth factor 2 mRNA-binding protein 1, transcript variant X7
insulin-like growth factor 2 mRNA-binding protein 1 isoform X7
protein dissatisfaction-like, transcript variant X2
protein dissatisfaction-like, transcript variant X1
protein dissatisfaction-like, transcript variant X3
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
collagen alpha-1(XI) chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
collagen alpha-1(XI) chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
ral GTPase-activating protein subunit beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ral GTPase-activating protein subunit beta, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ral GTPase-activating protein subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ral GTPase-activating protein subunit beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ral GTPase-activating protein subunit beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ral GTPase-activating protein subunit beta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ral GTPase-activating protein subunit beta isoform X1
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X4
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X6
ral GTPase-activating protein subunit beta isoform X5
multidrug resistance-associated protein 1, transcript variant X3
multidrug resistance-associated protein 1, transcript variant X2
multidrug resistance-associated protein 1, transcript variant X1
multidrug resistance-associated protein 1, transcript variant X4
multidrug resistance-associated protein 1, transcript variant X5
multidrug resistance-associated protein 1, transcript variant X6
multidrug resistance-associated protein 1, transcript variant X8
multidrug resistance-associated protein 1 isoform X2
multidrug resistance-associated protein 1 isoform X1
multidrug resistance-associated protein 1 isoform X3
multidrug resistance-associated protein 1 isoform X4
multidrug resistance-associated protein 1 isoform X5
multidrug resistance-associated protein 1 isoform X6
multidrug resistance-associated protein 1 isoform X8
multidrug resistance-associated protein 1, transcript variant X7
multidrug resistance-associated protein 1 isoform X7
cleft lip and palate transmembrane protein 1 homolog
DNA-directed RNA polymerase II subunit RPB9
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5
basic-leucine zipper transcription factor A-like, transcript variant X2
basic-leucine zipper transcription factor A-like, transcript variant X1
basic-leucine zipper transcription factor A-like, transcript variant X3
uncharacterized protein LOC122636448 isoform X2
uncharacterized protein LOC122636448 isoform X1
basic-leucine zipper transcription factor A-like isoform X3
NADH-ubiquinone oxidoreductase 49 kDa subunit-like
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X2
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X3
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X4
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X5
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X1
CCR4-NOT transcription complex subunit 9, transcript variant X1
CCR4-NOT transcription complex subunit 9, transcript variant X2
CCR4-NOT transcription complex subunit 9
sodium-coupled monocarboxylate transporter 2-like, transcript variant X2
sodium-coupled monocarboxylate transporter 2-like, transcript variant X1
sodium-coupled monocarboxylate transporter 2-like isoform X2
sodium-coupled monocarboxylate transporter 2-like isoform X1
metabotropic glutamate receptor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
metabotropic glutamate receptor 2-like, transcript variant X1
metabotropic glutamate receptor 2-like isoform X1
metabotropic glutamate receptor 2-like isoform X2
protein grindelwald, transcript variant X2
protein grindelwald, transcript variant X3
protein grindelwald, transcript variant X1
uncharacterized protein LOC122636544 isoform X3
growth factor receptor-bound protein 14-like, transcript variant X3
growth factor receptor-bound protein 14-like, transcript variant X1
growth factor receptor-bound protein 14-like, transcript variant X2
growth factor receptor-bound protein 14-like, transcript variant X8
growth factor receptor-bound protein 14-like, transcript variant X6
growth factor receptor-bound protein 14-like, transcript variant X9
growth factor receptor-bound protein 14-like, transcript variant X7
growth factor receptor-bound protein 14-like, transcript variant X5
growth factor receptor-bound protein 14-like, transcript variant X4
growth factor receptor-bound protein 14-like, transcript variant X11
growth factor receptor-bound protein 14-like, transcript variant X12
growth factor receptor-bound protein 14-like, transcript variant X10
growth factor receptor-bound protein 14-like isoform X3
growth factor receptor-bound protein 14-like isoform X1
growth factor receptor-bound protein 14-like isoform X2
growth factor receptor-bound protein 14-like isoform X5
growth factor receptor-bound protein 14-like isoform X4
growth factor receptor-bound protein 14-like isoform X6
growth factor receptor-bound protein 14-like isoform X8
growth factor receptor-bound protein 14-like isoform X7
growth factor receptor-bound protein 14-like isoform X9
SET and MYND domain-containing protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SET and MYND domain-containing protein 4, transcript variant X2
SET and MYND domain-containing protein 4
Y-box-binding protein 1, transcript variant X2
Y-box-binding protein 1, transcript variant X1
nuclear pore complex protein DDB_G0274915-like, transcript variant X1
nuclear pore complex protein DDB_G0274915-like, transcript variant X2
nuclear pore complex protein DDB_G0274915-like isoform X2
chitinase-like protein PB1E7.04c isoform X1
polycomb group protein Psc-like, transcript variant X4
polycomb group protein Psc-like, transcript variant X3
polycomb group protein Psc-like, transcript variant X1
polycomb group protein Psc-like, transcript variant X2
polycomb group protein Psc-like isoform X3
polycomb group protein Psc-like isoform X1
polycomb group protein Psc-like isoform X2
polycomb group protein Psc-like isoform X4
uncharacterized LOC122636546, transcript variant X1
uncharacterized LOC122636546, transcript variant X2
116 kDa U5 small nuclear ribonucleoprotein component
ras-related protein M-Ras-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ras-related protein M-Ras-like, transcript variant X1
ras-related protein M-Ras-like isoform X2
ras-related protein M-Ras-like isoform X1
transmembrane protein 132C, transcript variant X1
transmembrane protein 132C, transcript variant X2
transmembrane protein 132C, transcript variant X3
uncharacterized LOC122636538, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122636538, transcript variant X2
uncharacterized protein LOC122636538 isoform X1
uncharacterized protein LOC122636538 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 132C, transcript variant X4
39S ribosomal protein L16, mitochondrial
26S proteasome non-ATPase regulatory subunit 11
serine/threonine-protein kinase fused, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase fused, transcript variant X1
serine/threonine-protein kinase fused, transcript variant X4
serine/threonine-protein kinase fused isoform X2
serine/threonine-protein kinase fused isoform X1
serine/threonine-protein kinase 36 isoform X4
serine/threonine-protein kinase fused, transcript variant X3
serine/threonine-protein kinase fused isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cytochrome P450 306a1, transcript variant X2
cytochrome P450 306a1, transcript variant X1
putative zinc metalloproteinase YIL108W, transcript variant X2
putative zinc metalloproteinase YIL108W isoform X2
putative zinc metalloproteinase YIL108W, transcript variant X1
putative zinc metalloproteinase YIL108W isoform X1
pleckstrin homology domain-containing family A member 8, transcript variant X2
pleckstrin homology domain-containing family A member 8, transcript variant X3
pleckstrin homology domain-containing family A member 8, transcript variant X1
pleckstrin homology domain-containing family A member 8 isoform X1
pleckstrin homology domain-containing family A member 8 isoform X2
pleckstrin homology domain-containing family A member 8 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
astacin-like metalloprotease toxin 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
astacin-like metalloprotease toxin 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
astacin-like metalloprotease toxin 1 isoform X1
astacin-like metalloprotease toxin 5 isoform X2
U11/U12 small nuclear ribonucleoprotein 48 kDa protein-like
zinc finger protein 7-like, transcript variant X1
zinc finger protein 7-like, transcript variant X3
zinc finger protein 7-like, transcript variant X2
zinc finger protein 7-like, transcript variant X4
armadillo segment polarity protein, transcript variant X7
armadillo segment polarity protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
armadillo segment polarity protein, transcript variant X9
armadillo segment polarity protein, transcript variant X1
armadillo segment polarity protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
armadillo segment polarity protein, transcript variant X6
armadillo segment polarity protein, transcript variant X4
armadillo segment polarity protein, transcript variant X3
armadillo segment polarity protein, transcript variant X5
armadillo segment polarity protein, transcript variant X2
armadillo segment polarity protein isoform X1
armadillo segment polarity protein isoform X2
armadillo segment polarity protein isoform X3
atrial natriuretic peptide-converting enzyme-like, transcript variant X1
atrial natriuretic peptide-converting enzyme-like, transcript variant X5
atrial natriuretic peptide-converting enzyme-like, transcript variant X3
atrial natriuretic peptide-converting enzyme-like, transcript variant X2
atrial natriuretic peptide-converting enzyme-like, transcript variant X4
atrial natriuretic peptide-converting enzyme-like isoform X1
atrial natriuretic peptide-converting enzyme-like isoform X2
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X2
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X1
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X2
uncharacterized LOC122636429, transcript variant X1
uncharacterized LOC122636429, transcript variant X2
ribosomal RNA-processing protein 7 homolog A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ribosomal RNA-processing protein 7 homolog A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
ribosomal RNA-processing protein 7 homolog A isoform X2
ribosomal RNA-processing protein 7 homolog A isoform X1
uncharacterized protein C7orf26 homolog, transcript variant X2
uncharacterized protein C7orf26 homolog, transcript variant X1
uncharacterized protein C7orf26 homolog isoform X2
uncharacterized protein C7orf26 homolog isoform X1
exonuclease mut-7 homolog, transcript variant X2
exonuclease mut-7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
adenylate cyclase type 2-like, transcript variant X1
adenylate cyclase type 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
adenylate cyclase type 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
adenylate cyclase type 2-like, transcript variant X7
adenylate cyclase type 2-like, transcript variant X9
adenylate cyclase type 2-like, transcript variant X2
adenylate cyclase type 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
adenylate cyclase type 2-like isoform X1
adenylate cyclase type 2-like isoform X2
adenylate cyclase type 2-like, transcript variant X4
adenylate cyclase type 2-like, transcript variant X3
adenylate cyclase type 2-like isoform X3
ubiquitin recognition factor in ER-associated degradation protein 1, transcript variant X1
ubiquitin recognition factor in ER-associated degradation protein 1, transcript variant X2
ubiquitin recognition factor in ER-associated degradation protein 1 isoform X2
ubiquitin fusion degradation protein 1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vacuolar protein sorting-associated protein 29
cell cycle checkpoint control protein RAD9A, transcript variant X2
cell cycle checkpoint control protein RAD9A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
cell cycle checkpoint control protein RAD9A isoform X1
cell cycle checkpoint control protein RAD9A isoform X2
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/threonine-protein kinase CG17528, transcript variant X4
serine/threonine-protein kinase CG17528, transcript variant X1
serine/threonine-protein kinase CG17528, transcript variant X2
serine/threonine-protein kinase CG17528, transcript variant X3
serine/threonine-protein kinase CG17528 isoform X1
serine/threonine-protein kinase CG17528 isoform X2
serine/threonine-protein kinase CG17528 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
venom serine protease-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
venom serine protease-like, transcript variant X2
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X4
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X3
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X1
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X5
probable cytosolic iron-sulfur protein assembly protein Ciao1 isoform X1
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X2
probable cytosolic iron-sulfur protein assembly protein Ciao1 isoform X2
repressor of RNA polymerase III transcription MAF1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation elongation factor 1 epsilon-1, transcript variant X1
eukaryotic translation elongation factor 1 epsilon-1, transcript variant X2
eukaryotic translation elongation factor 1 epsilon-1 isoform X1
eukaryotic translation elongation factor 1 epsilon-1 isoform X2
kinesin-like protein KIF21A, transcript variant X3
kinesin-like protein KIF21A, transcript variant X1
kinesin-like protein KIF21A, transcript variant X2
kinesin-like protein KIF21A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase PSR
histone-lysine N-methyltransferase, H3 lysine-79 specific-like, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific-like, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-79 specific-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
histone-lysine N-methyltransferase, H3 lysine-79 specific-like, transcript variant X4
histone-lysine N-methyltransferase, H3 lysine-79 specific-like, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific-like isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific-like isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific-like isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 2-like
dnaJ protein homolog 1, transcript variant X1
dnaJ protein homolog 1, transcript variant X2
cilia- and flagella-associated protein 57
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X6
facilitated trehalose transporter Tret1-2 homolog, transcript variant X5
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X3
facilitated trehalose transporter Tret1-2 homolog, transcript variant X4
facilitated trehalose transporter Tret1-2 homolog isoform X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X8
facilitated trehalose transporter Tret1-2 homolog, transcript variant X7
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X9
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog isoform X3
dystroglycan-like, transcript variant X4
dystroglycan-like, transcript variant X1
dystroglycan-like, transcript variant X2
dystroglycan-like, transcript variant X3
dystroglycan-like, transcript variant X5
dystroglycan-like, transcript variant X6
uncharacterized protein LOC122636479 isoform X1
uncharacterized protein LOC122636479 isoform X2
uncharacterized protein LOC122636479 isoform X3
carbonic anhydrase 2, transcript variant X1
carbonic anhydrase 2, transcript variant X2
uncharacterized LOC122636485, transcript variant X2
uncharacterized LOC122636485, transcript variant X1
uncharacterized LOC122636485, transcript variant X3
uncharacterized protein LOC122636485 isoform X2
uncharacterized protein LOC122636485 isoform X1
uncharacterized protein LOC122636485 isoform X3
vacuolar protein sorting-associated protein 53 homolog, transcript variant X5
vacuolar protein sorting-associated protein 53 homolog, transcript variant X1
vacuolar protein sorting-associated protein 53 homolog, transcript variant X3
vacuolar protein sorting-associated protein 53 homolog, transcript variant X4
vacuolar protein sorting-associated protein 53 homolog, transcript variant X2
vacuolar protein sorting-associated protein 53 homolog
uncharacterized LOC122636512, transcript variant X1
uncharacterized LOC122636512, transcript variant X2